Your browser doesn't support javascript.
Risk factors for mortality of adult patients with COVID-19 hospitalised in an emerging country: a cohort study.
Cueto-Manzano, Alfonso M; Espinel-Bermúdez, María C; Hernández-González, Sandra O; Rojas-Campos, Enrique; Nava-Zavala, Arnulfo H; Fuentes-Orozco, Clotilde; Balderas-Peña, Luz Ma A; González-Ojeda, Alejandro; Cortes-Sanabria, Laura; Mireles-Ramírez, Mario A; Ramírez-Márquez, José J; Martínez-Gutiérrez, Porfirio E; Ávila-Morán, Maribel; De-Dios-Pérez, Ramón I; Acosta-Ramírez, Carlos; Hernández-García, Hugo R.
  • Cueto-Manzano AM; Unidad de Investigación Biomédica 02, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico a_cueto_manzano@hotmail.com.
  • Espinel-Bermúdez MC; Unidad de Investigación Biomédica 02, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Hernández-González SO; Unidad de Investigación Biomédica 02, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Rojas-Campos E; Unidad de Investigación Biomédica 02, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Nava-Zavala AH; Unidad de Investigación Biomédica 02, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Fuentes-Orozco C; Unidad de Investigación Biomédica 02, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Balderas-Peña LMA; Unidad de Investigación Biomédica 02, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • González-Ojeda A; Unidad de Investigación Biomédica 02, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Cortes-Sanabria L; Dirección de Investigación y Educación, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Mireles-Ramírez MA; Dirección de Investigación y Educación, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Ramírez-Márquez JJ; División de Epidemiología Hospitalaria, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Martínez-Gutiérrez PE; División de Tórax y Cardiovascular, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Ávila-Morán M; Departamento de Infectología, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • De-Dios-Pérez RI; Departamento de Admisión Médica Continua con Urgencias, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Acosta-Ramírez C; Dirección Médica, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
  • Hernández-García HR; Dirección General, Hospital de Especialidades Centro Médico Nacional de Occidente IMSS, Guadalajara, Mexico.
BMJ Open ; 11(7): e050321, 2021 07 19.
Article in English | MEDLINE | ID: covidwho-1318034
ABSTRACT

OBJECTIVE:

To describe mortality of in-hospital patients with COVID-19 and compare risk factors between survivors and non-survivors.

DESIGN:

Prospective cohort of adult inpatients.

SETTING:

Tertiary healthcare teaching hospital in Guadalajara, Mexico.

PARTICIPANTS:

All patients with confirmed COVID-19 hospitalised from 25 March to 7 September 2020 were included. End of study 7 November 2020. PRIMARY OUTCOME

MEASURES:

Patient survival analysed by the Kaplan-Meier method and comparison of factors by the log-rank test. Mortality risk factors analysed by multivariate Cox's proportional-hazard model.

RESULTS:

One thousand ten patients included 386 (38%) died, 618 (61%) alive at discharge and six (0.6%) remained hospitalised. There was predominance of men (63%) and high frequency of overweight-obesity (71%); hypertension (54%); diabetes (40%); and lung (9%), cardiovascular (8%) and kidney diseases (11%); all of them significantly more frequent in non-survivors. Overweight-obesity was not different between groups, but severity of disease (Manchester Triage System and quick Sequential Organ Failure Assessment) was significantly worse in non-survivors, who were also significantly older (65 vs 45 years, respectively) and had haematological, biochemical, coagulation and inflammatory biomarkers more altered than survivors. Mortality predictors were invasive mechanical ventilation (IMV; OR 3.31, p<0.0001), admission to intensive care unit (ICU; OR 2.18, p<0.0001), age (OR 1.02, p<0.0001), Manchester Triage System (urgent OR 1.44, p=0.02; immediate/very urgent OR 2.02, p=0.004), baseline C reactive protein (CRP; OR 1.002, p=0.009) and antecedent of kidney disease (OR 1.58, p=0.04)

CONCLUSIONS:

Mortality in hospitalised patients with COVID-19 in this emerging country centre seemed to be higher than in developed countries. Patients displayed a high frequency of risk factors for poor outcome, but the need for IMV, ICU admission, older age, more severe disease at admission, antecedent of kidney disease and higher CRP levels significantly predicted mortality.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Aged / Humans / Male Country/Region as subject: Mexico Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-050321

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Aged / Humans / Male Country/Region as subject: Mexico Language: English Journal: BMJ Open Year: 2021 Document Type: Article Affiliation country: Bmjopen-2021-050321